WAYNE, Pa., Oct. 23, 2015 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of SmartPros Ltd. ("SmartPros" or the "Company") (NASDAQ: SPRO) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Kaplan, Inc. a subsidiary of Graham Holdings in a transaction valued at approximately $16.9 million.

Ryan & Maniskas, LLP

If you own shares of SmartPros and would like to learn more about this class action or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/spro.  You may also email Mr. Maniskas at rmaniskas@rmclasslaw.com. 

Under the terms of the agreement, shareholders of SmartPros will receive $3.57 in cash for each share of SmartPros common stock owned.

Our investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of SmartPros for not acting in the Company's shareholders' best interests in connection with the sale process. 

Ryan & Maniskas, LLP is a national shareholder litigation firm.  Ryan & Maniskas, LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.  To learn more about the class action process, please visit: www.rmclasslaw.com.

CONTACT: Ryan & Maniskas, LLP
Richard A. Maniskas, Esquire
995 Old Eagle School Rd., Suite 311
Wayne, PA 19087
877-316-3218
www.rmclasslaw.com/cases/spro 
rmaniskas@rmclasslaw.com 

Logo - http://photos.prnewswire.com/prnh/20121112/MM11729LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ryan--maniskas-llp-announces-investigation-of-smartpros-ltd-300165455.html

SOURCE Ryan & Maniskas, LLP

Copyright 2015 PR Newswire

Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Spero Therapeutics Charts.
Spero Therapeutics (NASDAQ:SPRO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Spero Therapeutics Charts.